Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Shares Outstanding (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Shares Outstanding for 15 consecutive years, with $8.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 470.62% year-over-year to $8.0 million, compared with a TTM value of $8.0 million through Sep 2025, up 470.62%, and an annual FY2024 reading of $1.4 million, down 70.3% over the prior year.
  • Shares Outstanding was $1.4 million for Q3 2025 at BioRestorative Therapies, roughly flat from $1.4 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $6.9 million in Q3 2024 and bottomed at $793978.0 in Q1 2021.
  • Average Shares Outstanding over 5 years is $2.5 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Shares Outstanding tumbled 99.95% in 2021, then surged 470.62% in 2025.
  • Year by year, Shares Outstanding stood at $3.5 million in 2021, then tumbled by 56.88% to $1.5 million in 2022, then skyrocketed by 210.04% to $4.7 million in 2023, then tumbled by 70.3% to $1.4 million in 2024, then soared by 470.62% to $8.0 million in 2025.
  • Business Quant data shows Shares Outstanding for BRTX at $8.0 million in Q3 2025, $1.4 million in Q2 2025, and $1.4 million in Q1 2025.